Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

Journal of Clinical Oncology

Volumn 18, Issue 13, 2000, Pages 2505-2514

  Richardson, Mary Ann ^a   Sanders, Tina ^a   Palmer, J Lynn ^a   Greisinger, Anthony ^a   Singletary, S Eva ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CANCER CENTER; CANCER THERAPY; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

EID: 0033918159     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2000.18.13.2505     Document Type: Article

References (63)

1. Fisher P, Ward A: Complementary medicine in Europe. Br Med J 309:107-111, 1994
2. MacLennan AH, Wilson DH, Taylor AW: Prevalence and cost of alternative medicine in Australia. Lancet 347:569-573, 1996
3. Eisenberg DM, Davis RB, Ettner SL, et al: Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 280:1569-1575, 1998
4. Astin JA: Why patients use alternative medicine: Results of a national study. JAMA 279:1548-1553, 1998
5. Campion EW: Why unconventional medicine? N Engl J Med 328:282-283, 1993
6. Smith T: Alternative medicie. BMJ 287:307-308, 1983
7. Ernst E, Cassileth BR: The prevalence of complementary/alternative medicine in cancer. A systematic review. Cancer 83:777-782, 1998
8. McGinnis LS: Alternative therapies, 1990: An overview. Cancer 67:1788-1793, 1991
9. Burstein HJ, Gelber S, Guadagnoli E, et al: Use of alternative medicine by women with early-stage breast cancer. JAMA 340:1773-1739, 1999
10. Lerner IJ, Kennedy BJ: The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin 42:181-191, 1992
11. Cassileth BR, Lusk EF, Strouse TB, et al: Contemporary unorthodox treatments in cancer medicine: A study of patients, treatments, and practitioners. Ann Intern Med 101:105-112, 1984
12. Cassileth BR: Unorthodox cancer medicine. Cancer Invest 4:591-598, 1986
13. Richardson MA, Ramirez T, Nanney K, et al: Alternative/complementary medicine: Implications for patient-provider communication. Proc Am Soc Clin Oncol 18:590a, 1999 (abstr 2279)
14. Bourgeault I: Physicians' attitudes toward patients' use: of alternative cancer therapies. Can Med Assoc J 155:1679-1685, 1996
15. Neogi T, Oza AM: Use of alternative medicine: Are we failing in our communication with patients? A study assessing psychosocial impact of alternative medicine on cancer patients. Proc Am Soc Clin Oncol 17:416a, 1998 (abstr 1604)
16. Angell M, Kassirer P: Alternative medicine: The risks of untested and unregulated remedies. N Engl J Med 339:839-841, 1998
17. Levin JS, Glass TA, Kushi LH, et al: Quantitative methods in research on complementary and alternative medicine: A methodological manifesto. Med Care 35:1079-1094, 1997
18. DiPaola RS, Zhang H, Lambert GH, et al: Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 339:785-791, 1998
19. Coppes MJ, Anderson RA, Egeler RM, et al.: Alternative therapies for the treatment of childhood cancer. N Engl J Med 339:846-847, 1998
20. Coss RA, McGrath P, Caggiano V: Alternative care: Patient choices for adjunct therapies within a cancer center. Cancer Pract 6:176-181, 1998
21. Richardson MA: Overview of complementary/alternative medicine (CAM) activities. Presented at Nutritional Oncology Adjuvant Therapy Annual Meeting, Columbus, OH, November 6-7, 1998
22. Sparber A, Jonas W, White J, et al: Biomedical research and patient utilization of natural herbal products: A case study. Cancer Invest 18:436-439, 2000
23. Hosmer DW, Lemeshow S: Model-building strategies and methods for logistic regression, in Applied Logistic Regression. New York, NY, John Wiley & Sons, Inc, 1989, pp 82-134
24. Menard SW: Summary statistics for evaluating the logistic regression model, in Applied Logistic Regression Analysis. Thousand Oaks, CA, Sage Publications, 1995, pp 17-37
25. Druss B, Rosenheck RA: Association between use of unconventional therapies and conventional medical services. JAMA 282:651-656, 1999
26. Beckrow K, Wyatt G, Given C, et al: Complementary therapy use among older cancer patients. Support Care Cancer 7:172, 1999 (abstr O-36)
27. Faw C, Ballentine R, Ballentine L, et al: Unproved cancer remedies: A survey of use in pediatric outpatients. JAMA 238:1536-1538, 1978
28. Adler SR, Foskett JR: Disclosing complementary and alternative medicine use in the medical encounter: A qualitative study in women with breast cancer. J Fam Pract 48:453-458, 1999
29. Sollner W, Zingg-Schir M, Rumpold G, et al: Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol 133:316-321, 1997
30. Grothey A, Duppe J, Hasenburg A, et al: Use of alternative medicine in oncology [in German]. Dtsch Med Wochenschr 123:923-929, 1998
31. Obrist R, von Meiss M, Obrecht JP: The use of paramedical treatment methods by cancer patients: An inquiry on 101 ambulatory patients [in German]. Dtsch Med Wochenschr 111:283-287, 1986
32. Crocetti E, Crotti N, Feltrin A, et al: The use of complementary therapies by breast cancer patients attending conventional treatment. Eur J Cancer 34:324-328, 1999
33. Munstedt K, Kirsch K, Milch W, et al: Unconventional cancer therapy: Survey of patients with gynecological malignancy. Arch Gynecol Obstet 258:81-88, 1996
34. Verhoef MJ, Hagen N, Pelletier G, et al: Alternative therapy use in neurologic diseases. Neurology 52:617-622, 1999
35. Mottonen M, Uhari M: Use of micronutrients and alternative drugs by children with acute lymphoblastic leukemia. Med Pediatr Oncol 28:205-208, 1997
36. Begbie SD, Kerestes ZL, Bell DR: Patterns of alternative medicine use by cancer patients. Med J Aust 165:545-548, 1996
37. Downer SM, Cody MM, McCluskey P, et al: Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. Br Med J 309:86-89, 1994
38. Weis J, Bartsch H, Hennies F, et al: Complementary medicine in cancer patients: Demand, patients' attitude, and psychological belief. Onkologie 21:144-149, 1998
39. Risberg T, Lund E, Wist E, et al: The use of non-proven therapy among patients treated in Norwegian oncological departments: A cross-sectional national multicenter study. Eur J Cancer 31A: 1785-1789, 1995
40. Liu JM, Chu HC, Chin YH, et al: Cross sectional study of use of alternative medicines in Chinese cancer patients. Jpn J Clin Oncol 27:37-41, 1997
41. Oneschuk D, Fennell L, Hanson J, et al: The use of complementary medications by cancer patients attending an outpatient pain and symptom clinic. J Palliat Care 14:21-26, 1998
42. Risberg T, Lund E, Wist E: Use of non-proven therapies: Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol 34:893-898, 1995
43. Fernandez CV, Stutzer CA, MacWilliam L, et al: Alternative and complementary therapy use in pediatric oncology patients in British Columbia: Prevalence and reasons for use and nonuse. J Clin Oncol 16:1279-1286, 1998
44. Lee MM, Lin SS, Wrensch MR, et al: Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42-47, 2000
45. Ernst E: Harmless herbs? A review of the recent literature. Am J Med 104:170-178, 1998
46. Gurenwald J, Brendler T, Jaenicke C: PDR for Herbal Medicines. Montvale, NJ, Medical Economics Co, 1998
47. Labriola D, Livingston R: Possible interactions between dietary antioxidants and chemotherapy. Oncology 19:1003-1008, 1999
48. Lamson D, Brignall M: Antioxidants in cancer therapy: Their actions and interactions with oncologic therapies. Altern Med Rev 4:304-329, 1999
49. Weijl NI, Cleton FJ, Osanto S: Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209-240, 1997
50. Zeisel S, Salganik R: Special commentary: Antioxidants and nutrition support. Curr Opin Clin Nutr Metab Care 2:1-3, 1999
51. Jirillo A, Lacava J, Leone BA, et al: Survey on the use of questionable methods of cancer treatment. Tumori 82:215-217, 1996
52. Arkko PJ, Arkko BL, Kari-Kosinen O, et al: A survey of unproven cancer remedies and their users in an outpatient clinic for cancer therapy in Finland. Soc Sci Med 14A:511-514, 1980
53. Sawyer MG, Gannoni AF, Toogood IR, et al: The use of alternative therapies by children with cancer. Med J Aust 160:320-322, 1994
54. Miller L: Herbal medicinals: Selected clinical considerations focusing unknown or potential drug-herb interactions. Arch Intern Med 158:2200-2211, 1998
55. O'hara M, Kiefer DFK, Kemper K: A review of 12 commonly used medicinal herbs. Arch Fam Med 7:523-536, 1998
56. Ernst E: Second thoughts about safety of St. John's wort. Lancet 354:2014-2016, 1999
57. Durant JR: Alternative medicine: An attractive nuisance. J Clin Oncol 16:1-2, 1998
58. Nekolaichuk CL, Bruera E: On the nature of hope in palliative care. J Palliat Care 14:36-42, 1998
59. Yuen R, Mak Y, Chan A, et al: Preliminary study on use of traditional Chinese medicine and other complementary therapies by terminal cancer patients in Hong Kong. Presented at the 12th International Congress on Care of the Terminally Ill. Montreal, Canada, September 13-17, 1998
60. Pendergrass TW, Davis S: Knowledge and use of alternative cancer therapies in children. Am J Pediatr Hematol Oncol 3:339-345, 1981
61. Bailar JC, Gornik HL: Cancer undefeated. N Engl J Med 336:1569-1574, 1997
62. Hoey J: The arrogance of science and the pitfalls of hope. Can Med Assoc J 159:803-804, 1998
63. Stoll BA: Can unorthodox cancer therapy improve quality-of-life? Ann Oncol 4:121-123, 1993